http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3381909-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_015b06914223e1628bc6a0b3d09dcde5 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D251-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D251-18 |
| filingDate | 2017-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6626e52bfe7548cf378d0f0151099266 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42808ef85be7b1f6983d5a39998c640c |
| publicationDate | 2018-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-3381909-A1 |
| titleOfInvention | New triazine substance for use in the treatment of cancer, specifically in the treatment of non-small cell cancer, and pharmaceutical composition comprising said substance |
| abstract | Substance of formula (I) for use as a medicament nwherein A is a [-(CH 2 )n-] spacer, n being an integer comprised between 1 and 3, preferably between 1 and 2 ; X m are m substituents, m being an integer comprised between 1 and 3, wherein X is chosen among Cl, Br, OCH 3 or SCH 3 ; and R 1 , R 2 , R 3 and R 4 are chosen among hydrogen atoms or C 1 -C 3 alkyl groups. This substance has an anti-proliferative action on tumor cells and may advantageously be for use in the treatment of non-small cell cancer, preferably for use in the treatment of non-small cell squamous carcinoma, and more preferably for use in the treatment of non-small cell lung cancer. |
| priorityDate | 2017-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 126.